Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Al Hilli

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Seminars in Reproductive Medicine|April 24, 2010
Magnetic resonance-guided focused ultrasound surgeryMariam M Al Hilli, Elizabeth A Stewart
Nuklearmedizin. Nuclear Medicine|December 1, 1981
99mTc-labelled Cu(I)-EHDP, a potential skeletal imaging agentN H Agha, A M Al-Hilli, H A Hassen
The International Journal of Applied Radiation and Isotopes|May 1, 1984
Application of sodium stannite in the preparation of instant [99mTc]HIDA kitN H Agha, A M Al-Hilli, N D Dahir
Nuklearmedizin. Nuclear Medicine|October 1, 1983
Instant 99mTc-labelled glucoheptonate kit for kidney imagingN H Agha, M Al-Hilli, H M Karim, et al.
The International Journal of Applied Radiation and Isotopes|August 1, 1982
Ytterbium-169-phytate: a potential new radiopharmaceutical for functional scintigraphy of the liverN H Agha, A M Al-Hilli, H A Hassen, et al.
Nuklearmedizin. Nuclear Medicine|April 1, 1985
Preparation and biokinetic studies of 99mTc-p-butyl-IDA for hepatobiliary scintigraphyN H Agha, A M Al-Hilli, N D Dahir, et al.
Nuklearmedizin. Nuclear Medicine|October 1, 1986
Long-term clinical investigation of the hepatobiliary agents: 99mTc-HIDA and 99mTc-p-butyl-IDAN H Agha, A M Al-Hilli, N D Dahir, et al.
Obstetrics and Gynecology|July 9, 2014
Lymphedema after surgery for endometrial cancer: prevalence, risk factors, and quality of lifeKathleen J Yost, Andrea L Cheville, Mariam M Al-Hilli, et al.
Cureus|May 13, 2024
The Multi-faceted Effects of COVID-19 on Female Reproductive Health: An Updated Narrative ReviewAdnan A Al-Bdairi, Hayder A Makki, Osama Shawki, et al.
Gynecologic Oncology|November 27, 2015
The effect of diabetes and metformin on clinical outcomes is negligible in risk-adjusted endometrial cancer cohortsMariam M Al Hilli, Jamie N Bakkum-Gamez, Andrea Mariani, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Seminars in Reproductive Medicine|April 24, 2010
Magnetic resonance-guided focused ultrasound surgeryMariam M Al Hilli, Elizabeth A Stewart
Nuklearmedizin. Nuclear Medicine|December 1, 1981
99mTc-labelled Cu(I)-EHDP, a potential skeletal imaging agentN H Agha, A M Al-Hilli, H A Hassen
The International Journal of Applied Radiation and Isotopes|May 1, 1984
Application of sodium stannite in the preparation of instant [99mTc]HIDA kitN H Agha, A M Al-Hilli, N D Dahir
Nuklearmedizin. Nuclear Medicine|October 1, 1983
Instant 99mTc-labelled glucoheptonate kit for kidney imagingN H Agha, M Al-Hilli, H M Karim, et al.
The International Journal of Applied Radiation and Isotopes|August 1, 1982
Ytterbium-169-phytate: a potential new radiopharmaceutical for functional scintigraphy of the liverN H Agha, A M Al-Hilli, H A Hassen, et al.
Nuklearmedizin. Nuclear Medicine|April 1, 1985
Preparation and biokinetic studies of 99mTc-p-butyl-IDA for hepatobiliary scintigraphyN H Agha, A M Al-Hilli, N D Dahir, et al.
Nuklearmedizin. Nuclear Medicine|October 1, 1986
Long-term clinical investigation of the hepatobiliary agents: 99mTc-HIDA and 99mTc-p-butyl-IDAN H Agha, A M Al-Hilli, N D Dahir, et al.
Obstetrics and Gynecology|July 9, 2014
Lymphedema after surgery for endometrial cancer: prevalence, risk factors, and quality of lifeKathleen J Yost, Andrea L Cheville, Mariam M Al-Hilli, et al.
Cureus|May 13, 2024
The Multi-faceted Effects of COVID-19 on Female Reproductive Health: An Updated Narrative ReviewAdnan A Al-Bdairi, Hayder A Makki, Osama Shawki, et al.
Gynecologic Oncology|November 27, 2015
The effect of diabetes and metformin on clinical outcomes is negligible in risk-adjusted endometrial cancer cohortsMariam M Al Hilli, Jamie N Bakkum-Gamez, Andrea Mariani, et al.
Pageof 2